Emery, Sean <br/><br/>
The evaluation of subcutaneous proleukin (interleukin-2) in a randomized international trial: rationale, design, and methods of ESPRIT.  [electronic resource] 

 -  Controlled clinical trials  Apr 2002 
 - 198-220 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0197-2456 
<br/><br/><label>Standard No.: </label>10.1016/s0197-2456(01)00179-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Clinical Trials, Phase III as Topic--methods<br/>Data Collection--methods<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--drug therapy<br/>Humans<br/>Injections, Subcutaneous<br/>Interleukin-2--therapeutic use<br/>Male<br/>Multicenter Studies as Topic--methods<br/>Patient Selection<br/>Randomized Controlled Trials as Topic--economics<br/>Research Design<br/>Sample Size<br/>Survival Analysis<br/>United States